Table 4. Summary of main endpoints in the three included trials versus other trials.
| Trial | Follow-up duration | Occlusion metric | Parent vessel stenosis | Retreatment | Imaging modality | Core laboratory | 100% occlusion rate (%) |
| ATLAS, WEB-IT, LVIS | 1 year | 100% occlusion | >50 stenosis | Evaluated | DSA | Yes | |
| WEBCAST | 6 months | 100% occlusion or stable neck remnant | Not evaluated | Evaluated | DSA | Yes | 56 |
| WEBCAST 2 | 1 year | Not specified | Not evaluated | Evaluated | DSA 78% | Expert independently evaluated | 54 |
| CLARYS | 1 year | RR 1 | Not evaluated | Evaluated | 65% DSA | Yes | 41 |
ATLASSafety and Effectiveness of the Treatment of Wide Neck, Saccular Intracranial Aneurysms With the Neuroform Atlas Stent SystemCLARYSCLinical Assessment of WEB device in Ruptured aneurYSmsLVISPivotal Study of the Low Profile Visualized Intraluminal SupportWEBCASTWEB Clinical Assessment of Intrasaccular Aneurysm TherapyWEB-ITWoven EndoBridge Intrasaccular Therapy Study